It is a pleasure to present American pediatrics' most cherished award to a friend, who has served as my kindly mentor in pediatrics throughout our 26 years of association at the Children's Hospital. The American Pediatric Society has chosen Louis K. Diamond for this year's John Howland Award because he is and has been a great pediatrician, an extraordinarily effective teacher, a remarkably productive clinical investigator, and, for part of his career, an important public servant.
His academic career (Table I ) began in a New York Let us examine some highlights of Dr. Diamond's distinguished career. As an eager young man he prepared to enter medical school in 1923. Six years later, in 1929, he stands as a confident pediatric resident at the Children's Hospital, with his great teacher, Kenneth Blackfan (Fig. 1) . After Blackfan's untimely death from lung cancer, Dr. Richard M. Smith, an eminent practitioner, served as Head of the Department of Pediatrics through the period of the second World War on condition that three younger men-Diamond, Clement Smith, and John Davies-would carry the bulk of the clinical and teaching load.
Up to this time, Dr. Diamond, like most of the younger clinical teachers of that period, had had to supplement his meager academic salary by pediatric practice: an experience which gave his clinical teaching a strong foundation in reality, and deepened his understanding of patients and their parents. The opportunity to devote himself full time to academic pediatrics came in 1942, when, in order to apply the new knowledge of the Rh system to blood transfusion and the management of erythroblastosis, Dr. Diamond organized the Blood Grouping Laboratory, which became a world-renowned center for research on this disease and a regional center for its treatment. With this laboratory as a base for work on erythroblastosis, and with what then seemed like an enormous grant of 10,000 Because of his expertise in this field, Dr. Diamond was soon enlisted as a collaborator by Professor Edwin Cohn, who was developing the methods of plasma fractionation during the early Forties. Dr. Diamond was the first pediatrician to use a purified human plasma fraction in the management of hemophilia in children. This chart, prepared by Dr. Diamond, shows the effect of fraction I on the coagulation time of a boy with hemophilia, who was carried successfully through a dental extraction without excessive bleeding (Fig. 2) . This study depicting both the observable clinical effect and laboratory proof of the action of antihemophilic globulin, is typical of Dr. Diamond's clinical research. He had the complete confidence of his patients; he needed no Committee on Human Investigation to monitor his instinctive ethical standards, and he could plan and carry out a decisive clinical trial.
It was his involvement in the work of Dr. Cohn's group, and his expertise in the field of blood transfusion, that led to his selection as the first Technical Director for the newly created National Blood Program of the American Red Cross in 1948. This was an arduous, and sometimes tedious pioneering task, but in 3 years, he was able to establish high technical standards for a program which has become one of the major health resources of this country.
Upon his return from this taxing administrative job, he devoted himself full time to pediatric teaching and research, to sharing my responsibilities for patient care as Associate Physician-in-Chief of the hospital, and for the department as its head during my two sabbatical leaves. He also began the serious business of training pediatric hematologists. The record of his pediatric hematology training program is an extraordinary one. Had all other training programs been like it, we would probably not be involved in our present difficulties over training grants. His 60 or more former trainees are located in 16 states and 13 foreign countries. Many of them are full professors; almost everyone of them is in an academic position. It was a rigorous program, involving a healthy mix of clinical responsibility for patients with research activities in the various laboratories he had established. However, it wasn't all work and no play. This group of trainees, with their master, don't look too downtrodden (Fig. 3) . It includes Doris Howell to his right, now Chairman of the Department of Pediatrics at the Medical College of Pennsylvania, and on his left, Jack Hartmann, Pro- fessor of Pediatrics and Hematologist-Oncologist at the Children's Orthopedic Hospital in Seattle. What has made Lou Diamond so effective? First, he is an exceptionally dedicated physician, able to concentrate every faculty, as well as his vast store of knowledge and clinical experience upon helping his patient. Second, he is an investigator who has always been quick to see the clinical possibilities arising out of scientific advances. Third, he has had the drive to turn his vision of such potentialities into reality. For example, in 1932, with Baty and Blackfan, he presented evidence, from a detailed pathologic and clinical analysis of 20 cases and an extensive review of the literature, that what had previously been considered four different diseases-fetal death with erythroblastosis in the tissues, fetal hydrops, congenital anemia of the newborn, and icterus gravis neonatorum-were differing clinical manifestations of a single pathologic process, called erythroblastosis fetalis [6] . Nine years later, Philip Levine showed that this process was due to isoimmunization of an Rh-negative mother by the red cells of an Rh-positive fetus. Following this discovery, Dr. Diamond enlisted the collaboration of a group of Boston hospitals in founding the Blood Grouping Laboratory, to provide the necessary laboratory support for clinical application of this new knowledge. He worked out a method with Neva Abelson and Ronald Denton for titration of the IgG antibody which produced the disease, as distinct from the IgM antibody which did not cross the placenta [3, 7] . With F. H. Allen [5] he developed a simple, practical technique for exchange transfusion which had already been suggested for treatment by others. During the next two decades, he and his collaborators-Fred Allen, Victor Vaughan, Sydney Gellis, and David Hsia-systematized the indications for exchange transfusion, not just to save life, but to prevent brain damage from kernicterus [1, 4] . For this he received, with Wiener and Levine, the Award for Scientific Research in Mental Retardation of the Joseph P. Kennedy, Jr., International Foundation. As he wrote in Pediatrics for January 1968, "Rarely has it been our good fortune to have a disease recognized, its cause clearly determined, its treatment successfully developed to a great extent and then its prevention found, all in one generation" [2] . Lou Diamond played a major role in this great achievement, and for that alone deserves a place in the pediatric hall of fame, but there are many other reasons for his selection for the John Howland Award.
Dr. Diamond's experience in the Blood Grouping Laboratory made him an international figure. Here is a picture taken in Cambridge, England, of what might be called the "four horsemen of the blood groups," Fisher and Race, the basic scientists on the right, and on the left, Diamond and Mollison, who applied their work to patients on both sides of the Atlantic (Fig. 4) . These international visits had their lighter moments, such as a tour of the pubs with Race, the inevitable results showing on the return trip to London by train (Fig. 5) .
The blood groups led Dr. Diamond far into human genetics. He foresaw its tremendous importance for pediatrics, encouraged Park Gerald to enter the field, sent him to London to study, and established laboratories for him at the Children's Hospital. Dr. Diamond also recognized the importance of biochemistry for elucidating the pathogenesis of the various hemolytic syndromes of childhood. For this, he was able to lure his successor, David Nathan, from Frank Gardner's laboratory in the department of medicine into pediatrics and thus to assure a bright future for the hematology division he had created. There are many other facets of his research-on the spleen or on aplastic anemia, and his encouragement of Chester Alper in automating immunochemical measurement of the plasma proteins-which we must omit for lack of time.
In closing this introduction of the 1973 Howland awardee, who was president of this society in 1966, we must pay our respects to someone whose loyalty and support have made his accomplishments possible. Flo Diamond not only brought music into Lou's life, but contributed a remarkable set of genes, as shown by the careers of their talented, able children.
And now, Dr. Diamond, the podium is yours as the recipient of the John Howland Award for 1973.
